157 related articles for article (PubMed ID: 26279462)
1. Von Hippel-Lindau Syndrome.
Ben-Skowronek I; Kozaczuk S
Horm Res Paediatr; 2015; 84(3):145-52. PubMed ID: 26279462
[TBL] [Abstract][Full Text] [Related]
2. From arterial hypertension complications to von Hippel-Lindau syndrome diagnosis.
Kozaczuk S; Ben-Skowronek I
Ital J Pediatr; 2015 Aug; 41():56. PubMed ID: 26268347
[TBL] [Abstract][Full Text] [Related]
3. Nervous system involvement in von Hippel-Lindau disease: pathology and mechanisms.
Vortmeyer AO; Falke EA; Gläsker S; Li J; Oldfield EH
Acta Neuropathol; 2013 Mar; 125(3):333-50. PubMed ID: 23400300
[TBL] [Abstract][Full Text] [Related]
4. [Von Hippel-Lindau disease and renal cancer: 10 years of genetic progress. GEFVHL (French-Speaking Study Group on von Hippel-Lindau disease)].
Richard S; Beroud C; Joly D; Chretien Y; Benoit G
Prog Urol; 1998 Jun; 8(3):330-9. PubMed ID: 9689663
[TBL] [Abstract][Full Text] [Related]
5. Von Hippel-Lindau: how a rare disease illuminates cancer biology.
Richard S; Gardie B; Couvé S; Gad S
Semin Cancer Biol; 2013 Feb; 23(1):26-37. PubMed ID: 22659535
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic analysis of von Hippel-Lindau disease.
Richards FM; Webster AR; McMahon R; Woodward ER; Rose S; Maher ER
J Intern Med; 1998 Jun; 243(6):527-33. PubMed ID: 9681854
[TBL] [Abstract][Full Text] [Related]
7. Von Hippel Lindau syndrome.
Kim JJ; Rini BI; Hansel DE
Adv Exp Med Biol; 2010; 685():228-49. PubMed ID: 20687511
[TBL] [Abstract][Full Text] [Related]
8. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
Richard S;
Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
[TBL] [Abstract][Full Text] [Related]
9. Manifestations of Von Hippel Lindau syndrome: a retrospective national review.
O' Brien FJ; Danapal M; Jairam S; Lalani AK; Cunningham J; Morrin M; McNally S; Donovan MG; Little D; Tuthill A; Conlon PJ
QJM; 2014 Apr; 107(4):291-6. PubMed ID: 24352051
[TBL] [Abstract][Full Text] [Related]
10. [Von Hippel-Lindau disease: protocols for diagnosis and periodical clinical monitoring. National Von Hippel-Lindau Disease Working Group].
Hes FJ; van der Luijt RB
Ned Tijdschr Geneeskd; 2000 Mar; 144(11):505-9. PubMed ID: 10735135
[TBL] [Abstract][Full Text] [Related]
11. [Von Hippel-Lindau disease: recent advances in genetics and clinical management].
Richard S; Parker F; Aghakhani N; Allegre G; Portier F; David P; Marsot-Dupuch K
J Neuroradiol; 2005 Jun; 32(3):157-67. PubMed ID: 16134297
[TBL] [Abstract][Full Text] [Related]
12. [Von Hippel-Lindau disease and central nervous system hemangioblastoma. Progress in genetics and clinical management].
Richard S; Martin S; David P; Decq P
Neurochirurgie; 1998 Nov; 44(4):258-66. PubMed ID: 9864697
[TBL] [Abstract][Full Text] [Related]
13. Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease.
Granata A; Sessa A; Righetti M; Cordaro S; Leone G; Figura M; Fatuzzo P; Rapisarda F; Di Maria E; Ciotti P; Mandich P; Nardo A; Ferrone M; Gallone S; Liuzzo G
J Nephrol; 2004; 17(2):306-10. PubMed ID: 15293534
[TBL] [Abstract][Full Text] [Related]
14. [Gastroenterological manifestations of von Hippel-Lindau disease].
Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
Pol Merkur Lekarski; 2017 Aug; 43(254):53-55. PubMed ID: 28875969
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease.
Zwolak A; Świrska J; Tywanek E; Dudzińska M; Tarach JS; Matyjaszek-Matuszek B
Endokrynol Pol; 2020; 71(3):256-259. PubMed ID: 32797472
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterisation of sporadic endolymphatic sac tumours and comparison to von Hippel-Lindau disease-related tumours.
Schweizer L; Thierfelder F; Thomas C; Soschinski P; Kim HY; Jödicke R; Woltering N; Förster A; Teichmann D; Siewert C; Klein K; Schmid S; Nunninger M; Thomale UW; Onken J; Mühleisen H; Schittenhelm J; Tatagiba M; von Deimling A; Reuss DE; Solomon DA; Heppner FL; Koch A; Hartmann C; Staszewski O; Capper D
Neuropathol Appl Neurobiol; 2021 Oct; 47(6):756-767. PubMed ID: 34091929
[TBL] [Abstract][Full Text] [Related]
17. Chromogranin a expression in phaeochromocytomas associated with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2.
Cleary S; Phillips JK; Huynh TT; Pacak K; Fliedner S; Elkahloun AG; Munson P; Worrell RA; Eisenhofer G
Horm Metab Res; 2007 Dec; 39(12):876-83. PubMed ID: 18046660
[TBL] [Abstract][Full Text] [Related]
18. [Hippel-Lindau disease].
Krzystolik K; Cybulski C; Lubiński J
Neurol Neurochir Pol; 1998; 32(5):1119-33. PubMed ID: 10463227
[TBL] [Abstract][Full Text] [Related]
19. Clinical management of Von Hippel-Lindau (VHL) disease.
Hes FJ; van der Luijt RB; Lips CJ
Neth J Med; 2001 Nov; 59(5):225-34. PubMed ID: 11705642
[TBL] [Abstract][Full Text] [Related]
20. Endolymphatic sac tumours and von Hippel-Lindau disease - case report, molecular analysis and histopathological characterization.
Krzysztolik K; Cybulski C; Sagan L; Nowacki P; Lubiński J
Folia Neuropathol; 2009; 47(1):75-80. PubMed ID: 19353437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
